Loading
companiesCompany
Abbott Laboratories
Diagnostics giant that makes the UroVysion bladder test, sells Freenome's blood test for bowel cancer, and is acquiring Exact Sciences.
Overview
Abbott Molecular's UroVysion (FDA 2001 and 2005) and Vysis FISH probes are long-standing oncology diagnostics. In 2025-26 Abbott moved decisively into cancer screening: it holds US commercial rights to Freenome's SimpleScreen CRC (approved July 2026) and agreed to acquire Exact Sciences (Cologuard, Oncotype DX) for about $21 billion.
Headquarters
Abbott Park, IL, US
Scorecard
All companies#283of 1244 companies, score 15
- approved products +12
- modalities +2
- regions +1
2 approved, 0 in phase 3, 0 earlier, 0 targets, 0 registry studies. Formula on the scorecards page.
Type
Diagnostics · ABT
Stage
Public
Website
Founded
1888
ApprovedUrine FISH cytogenetic test (bladder cancer)
UroVysion Bladder Cancer Kit · UroVysion
A urine test that looks for chromosome changes in shed bladder cells, approved for people with blood in the urine and for follow-up after bladder cancer.
ApprovedBlood-based colorectal cancer screening test (cfDNA methylation and protein)
SimpleScreen CRC · SimpleScreen
The second FDA-approved blood test for bowel cancer screening, from Freenome, sold by Abbott from late 2026.
Similar pages
- Key paperClinical validation of a circulating tumor DNA-based blood test to screen for colorectal cancer (PREEMPT CRC)
Shares SimpleScreen CRC, Freenome, Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Colorectal cancer.
- TrialPREEMPT CRC
Shares SimpleScreen CRC, Freenome, Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Colorectal cancer.
- TreatmentCxbladder
Shares UroVysion Bladder Cancer Kit, Urine tests for bladder cancer (cytology, FISH, RNA and methylation), Bladder & urothelial cancer.
- TreatmentCologuard Plus
Shares SimpleScreen CRC, Exact Sciences (Abbott), Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Colorectal cancer.
- TechnologyCystoscopy, blue-light imaging & TURBT
Shares UroVysion Bladder Cancer Kit, Urine tests for bladder cancer (cytology, FISH, RNA and methylation), Bladder & urothelial cancer.
- TrialDeeP-C
Shares Exact Sciences (Abbott), Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Colorectal cancer.
- CompanyPacific Edge
Shares Urine tests for bladder cancer (cytology, FISH, RNA and methylation), Bladder & urothelial cancer.
- TrialBLUE-C
Shares Exact Sciences (Abbott), Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Colorectal cancer.
cancers
fronts
technologies
drugs
ApprovedBlood-based colorectal cancer screening test (cfDNA methylation and protein)
SimpleScreen CRC · SimpleScreen
ApprovedUrine FISH cytogenetic test (bladder cancer)
UroVysion Bladder Cancer Kit · UroVysion